Stockscreener 앱 받기
32.82
0.42%
-0.14
시간 외 거래:
32.82
전일 마감가:
$32.96
열려 있는:
$33.33
하루 거래량:
645.65K
Relative Volume:
0.48
시가총액:
$1.18B
수익:
$117.67M
순이익/손실:
$-1.88B
주가수익비율:
-0.5421
EPS:
-60.5369
순현금흐름:
$-621.36M
1주 성능:
+0.09%
1개월 성능:
-23.39%
6개월 성능:
+1.89%
1년 성능:
+88.08%
1일 변동 폭
$32.25
$33.42
1주일 범위
$31.75
$34.52
52주 변동 폭
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
명칭
Grail Inc
전화
(833) 694-2553
주소
1525 O'BRIEN DRIVE, MENLO PARK
GRAL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
32.82 | 1.19B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Canaccord Genuity | Buy |
| 2024-11-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-10-17 | 개시 | Guggenheim | Neutral |
Grail Inc 주식(GRAL)의 최신 뉴스
8 Stocks Jeff Bezos Is Buying - Money/ US News
Illumina’s SomaLogic acquisition may face GRAIL-like regulatory hurdles - ION Analytics
How strong is GRAIL LLC company’s balance sheetUnlock steady growth with low-risk stocks - Jammu Links News
Is it the right time to buy GRAIL LLC stockHigh-yield capital appreciation - Jammu Links News
What is GRAIL LLC company’s growth strategyUnprecedented market success - Jammu Links News
What makes GRAIL LLC stock price move sharplyMaximize your portfolio’s growth with expert tips - Jammu Links News
Why is GRAIL LLC stock attracting strong analyst attentionInvest with confidence backed by data - Jammu Links News
How volatile is GRAIL LLC stock compared to the marketRetirement Planning Review With Proven Results - jammulinksnews.com
Commit To Purchase Grail At $20, Earn 21.5% Using Options - Nasdaq
Early Cancer Detection Pioneer GRAIL Reveals Latest Innovations at Canaccord Growth Conference - Stock Titan
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference - PR Newswire
What analysts say about GRAIL LLC stock outlookAI Based High Gain Watchlist Scanner Shared - beatles.ru
Drawdown in GRAIL LLC May Be Nearing EndFast Gaining Stock Screener Reports Released - beatles.ru
GRAIL LLC Shows Risk Reward Favoring UpsideAI Screening for Swing Trade Picks Finds Momentum - metal.it
GRAIL Announces Q2 2025 Financial Results and Upcoming Webcast and Conference Call - AInvest
GRAIL to Announce Second Quarter 2025 Financial Results - WV News
Cancer Detection Pioneer GRAIL Sets Q2 Earnings Call: Key Details for Healthcare Investors - Stock Titan
When is the best time to buy GRAIL LLC stockWeekly Stock Watch With Growth Focus Expanded - beatles.ru
What markets is GRAIL LLC expanding into Is Cadiz Inc. stock a good long term investment optionDiscover high-impact stocks for your portfolio - Jammu Links News
What institutional investors are buying GRAIL LLC stockRapid portfolio appreciation - jammulinksnews.com
How many analysts rate GRAIL LLC as a “Buy”Robust investment performance - jammulinksnews.com
Is GRAIL LLC stock overvalued or undervaluedUnlock the power of real-time market data - jammulinksnews.com
Is GRAIL LLC a good long term investmentExplosive earning power - PrintWeekIndia
What analysts say about GRAIL LLC stockFree Stock Market Real-Time Monitoring - PrintWeekIndia
"The Grail Collection" Could Be a Game-Changer for MDCE (OTC:MDCE)Jordan, Curry, and NBA Royalty Up for Bid - ACCESS Newswire
Minimal Residual Disease Testing Market Trends Analysis Report 2025-2030 | North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem - GlobeNewswire Inc.
GRAIL LLC Stock Analysis and ForecastBreakout portfolio performance - Autocar Professional
What drives GRAIL LLC stock priceHigh-yield trading alerts - Autocar Professional
Grail, Inc. shares rise 6.49% intraday as Dynatrace announces advancements in its 3rd generation platform. - AInvest
Freenome's new CEO is ready to compete in race for tests that can detect cancer earlySan Francisco Business Times - The Business Journals
(GRAL) Technical Data - news.stocktradersdaily.com
Grail posts latest trial data for Galleri cancer detection test - MSN
Grail’s CFO Freidin sells $311k in common stock By Investing.com - Investing.com India
Grail’s CFO Freidin sells $311k in common stock - Investing.com Australia
Grail (GRAL) PT Hiked to $38 at Morgan Stanley amid ‘Equal Weight’ Stance - MSN
Grail (GRAL) Plummets 10%—What’s Behind the Sell-Off? - AInvest
GRAIL’s Galleri Multi-Cancer Test Shows Strong Performance in PATHFINDER 2 Study, Paves Way for FDA Submission - MSN
12 Best Young Stocks To Buy and Hold For 5 Years - Insider Monkey
Illumina: A Compelling Buy Despite GRAIL Divestiture and Macroeconomic Challenges - AInvest
Grail Inc (GRAL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):